Cargando…
A digestive allergic reaction with hypereosinophilia imputable to docetaxel in a breast cancer patient: a case report
BACKGROUND: Hypereosinophilia, defined by an absolute eosinophil count of more than 1500/mm3, is rarely observed in patients treated for cancer, and rarely imputable to anti-cancer agents. Drug-induced hypereosinophilia usually appears within a few weeks of the start of treatment and resolves after...
Autores principales: | Hamdan, Diaddin, Leboeuf, Christophe, Pereira, Cathy, Jourdan, Nathalie, Verneuil, Laurence, Bousquet, Guilhem, Janin, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727412/ https://www.ncbi.nlm.nih.gov/pubmed/26810399 http://dx.doi.org/10.1186/s12885-015-2008-0 |
Ejemplares similares
-
Re‐exploring immune‐related side effects of docetaxel in an observational study: Blood hypereosinophilia
por: Hamdan, Diaddin, et al.
Publicado: (2019) -
Genomics applied to the treatment of breast cancer
por: Hamdan, Diaddin, et al.
Publicado: (2019) -
Tracking sub-clonal TP53 mutated tumor cells in human metastatic renal cell carcinoma
por: Bousquet, Guilhem, et al.
Publicado: (2015) -
Expression of angiopoietin-like 4 fibrinogen-like domain (cANGPTL4) increases risk of brain metastases in women with breast cancer
por: Dao, Tu, et al.
Publicado: (2020) -
Donor-derived stem-cells and epithelial mesenchymal transition in squamous cell carcinoma in transplant recipients
por: Verneuil, Laurence, et al.
Publicado: (2015)